Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like 7 PDUFA Dates to Mark on Your Calendars for September September 5, 2017 Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline May 31, 2017 ArQule To Present Clinical Data At The 2017 ASCO Annual Meeting May 17, 2017
